Report Library
All Reports
Biomedtracker Q4 2018 Outlook Report
October 04, 2018
In this report, we cover catalysts from 27 drugs expected to occur in Q4 2018. For each drug, the likelihood of
Phase/PDUFA review
success and overall Likelihood of Approval (LOA) given their particular phase, drug class, and disease group are
provided. The results of
the catalysts highlighted in our Q3 2018 Outlook Report can be
found on Page 4. At the
end
of this report, we have included a list of Large Impact catalysts through Q4 2018.
For the full report, please download the PDF version at the top of this page. Additionally, the catalyst list is provided in Excel by downloading the supplemental material at the top of this page.
Interested in medical devices? Our sister product Meddevicetracker has published a concurrent report on 11 device catalysts expected to occur in Q4 2018. This report can be downloaded for free here.
Like our report? Have any questions or feedback? Please let us know at askanalyst@sagientresearch.com.
For our disclosures, please read the Biomedtracker Research Standards.
For the full report, please download the PDF version at the top of this page. Additionally, the catalyst list is provided in Excel by downloading the supplemental material at the top of this page.
Interested in medical devices? Our sister product Meddevicetracker has published a concurrent report on 11 device catalysts expected to occur in Q4 2018. This report can be downloaded for free here.
Like our report? Have any questions or feedback? Please let us know at askanalyst@sagientresearch.com.
For our disclosures, please read the Biomedtracker Research Standards.
| Indications Covered: |
Acute Pain
Anemia Attention Deficit Hyperactivity Disorder (ADHD) Breast Cancer Cardiovascular Disease Charcot-Marie-Tooth Disease Chronic Idiopathic Constipation Diabetes Mellitus, Type II Fungal Infections - Systemic Hepatitis B (HBV) Treatment (Antiviral) Hereditary Transthyretin (hATTR) Amyloidosis With Polyneuropathy (Familial Amyloid Polyneuropathy) HIV / AIDS Treatment Lambert-Eaton Myasthenic Syndrome (LEMS) Leukopenia / Neutropenia Major Depressive Disorder (MDD) Moderate to Severe Pain Multiple Myeloma (MM) Narcolepsy Renal Cell Cancer (RCC) Schizophrenia Solid Tumors Substance Use Disorder |
Additional Resources: